Conference will engage leaders from academia and the pharmaceutical
and biotechnology industries
WILMINGTON, Mass.--(BUSINESS WIRE)--Aug. 15, 2017--
Breakthroughs begin here. At the Inaugural Charles River World
Congress on Animal Models in Drug Discovery & Development,
leaders from across academia and the pharmaceutical and biotechnology
industries will convene to discuss how to bridge the gap between drug
discovery and clinical application.
The World Congress on Animal Models
is a two-day scientific program presented in association with the annual
BioPharm America™ Conference. This year’s World Congress on Animal
Models will focus on the bedside-to-bench experience, driven by
innovations and breakthroughs in translational tools and methods in drug
discovery research and development.
Dates: September 26-27, 2017
Location: Sheraton Copley Place, Boston, MA
Access: Attendees at the World Congress on Animal Models
also receive full access to BioPharm America™ and all Biotech
Week Boston events
Registration: To learn more and register, visit breakthroughs.criver.com
Join the Conversation: Follow #CRLworldcon on social media
“There has never been a more exciting time in drug discovery.
Innovation is at an all-time high and reverse translational medicine
is a key to that innovation. I am proud that Charles River is leading
the discussion on developing translatable models.” –James C. Foster,
Chairman, President and CEO at Charles River
“The depth of knowledge and experience we are bringing together is
really one-of-a-kind. To have these thought leaders together in one
place, discussing the future of translational medicine, will pave the
way for future breakthroughs.” –Joe Cornicelli, PhD, Program Director
for the World Congress on Animal Models
About Charles River
Charles River provides essential
products and services to help pharmaceutical and biotechnology
companies, government agencies and leading academic institutions around
the globe accelerate their research and drug development efforts. Our
dedicated employees are focused on providing clients with exactly what
they need to improve and expedite the discovery, early-stage development
and safe manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170815005556/en/
Source: Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc.
Corporate Vice President, Public Relations